Open Label Oral Aripiprazole in Patients with Tourette’s Disorder

• Research type

  Research Study

• Full title

  An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents with Tourette’s Disorder

• IRAS ID

  121958

• Contact name

  Andrea Cavanna

• Contact email

  andrea.cavanna@bsmhft.nhs.uk

• Sponsor organisation

  Otsuka Pharmaceutical Development & Commercialization, Inc.

• Eudract number

  2012-003489-42

• ISRCTN Number

  n.a

• REC name

  West Midlands - Coventry & Warwickshire Research Ethics Committee

• REC reference

  13/WM/0061

• Date of REC Opinion

  10 Apr 2013

• REC opinion

  Further Information Favourable Opinion